Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Day

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Cancer|June 1, 1984
Cigarette smoking and malignant melanoma. Prognostic implicationsH K Koh, A J Sober, C L Day, et al.
Biochemistry|November 19, 1996
Mutation of arginine 121 in lactoferrin destabilizes iron binding by disruption of anion binding: crystal structures of R121S and R121E mutantsH R Faber, C J Baker, C L Day, et al.
JAMA|February 4, 1983
Multivariate analysis. Some guidelines for physiciansR A Lew, C L Day, T J Harrist, et al.
Journal of Molecular Biology|December 5, 1992
Preliminary crystallographic studies of the amino terminal half of human lactoferrin in its iron-saturated and iron-free formsC L Day, G E Norris, B F Anderson, et al.
Cell Death and Differentiation|June 12, 2002
Tissue distribution of Diablo/Smac revealed by monoclonal antibodiesA Tikoo, L O'Reilly, C L Day, et al.
Cell Death and Differentiation|January 26, 2008
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in transK Linke, P D Mace, C A Smith, et al.
Journal of Molecular Biology|February 23, 1996
Altered domain closure and iron binding in transferrins: the crystal structure of the Asp60Ser mutant of the amino-terminal half-molecule of human lactoferrinH R Faber, T Bland, C L Day, et al.
Journal of the American Academy of Dermatology|October 1, 1983
Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomasA R Rhodes, T J Harrist, C L Day, et al.
CA: a Cancer Journal for Clinicians|March 1, 1982
Cutaneous malignant melanoma: prognostic guidelines for physicians and patientsC L Day, M C Mihm, R A Lew, et al.
The Journal of Investigative Dermatology|June 1, 1983
Early death from clinical stage I melanomaA J Sober, C L Day, T B Fitzpatrick, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Cancer|June 1, 1984
Cigarette smoking and malignant melanoma. Prognostic implicationsH K Koh, A J Sober, C L Day, et al.
Biochemistry|November 19, 1996
Mutation of arginine 121 in lactoferrin destabilizes iron binding by disruption of anion binding: crystal structures of R121S and R121E mutantsH R Faber, C J Baker, C L Day, et al.
JAMA|February 4, 1983
Multivariate analysis. Some guidelines for physiciansR A Lew, C L Day, T J Harrist, et al.
Journal of Molecular Biology|December 5, 1992
Preliminary crystallographic studies of the amino terminal half of human lactoferrin in its iron-saturated and iron-free formsC L Day, G E Norris, B F Anderson, et al.
Cell Death and Differentiation|June 12, 2002
Tissue distribution of Diablo/Smac revealed by monoclonal antibodiesA Tikoo, L O'Reilly, C L Day, et al.
Cell Death and Differentiation|January 26, 2008
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in transK Linke, P D Mace, C A Smith, et al.
Journal of Molecular Biology|February 23, 1996
Altered domain closure and iron binding in transferrins: the crystal structure of the Asp60Ser mutant of the amino-terminal half-molecule of human lactoferrinH R Faber, T Bland, C L Day, et al.
Journal of the American Academy of Dermatology|October 1, 1983
Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomasA R Rhodes, T J Harrist, C L Day, et al.
CA: a Cancer Journal for Clinicians|March 1, 1982
Cutaneous malignant melanoma: prognostic guidelines for physicians and patientsC L Day, M C Mihm, R A Lew, et al.
The Journal of Investigative Dermatology|June 1, 1983
Early death from clinical stage I melanomaA J Sober, C L Day, T B Fitzpatrick, et al.
Pageof 7